Santara Valley experience in new health technologies. Vladas Algirdas Bumelis

Transcription

1 Santara Valley experience in new health technologies Vladas Algirdas Bumelis 1

2 Santara Valley Integrated scientific and business center was established in It will be finished by the end of Main objectives are: biotechnology, molecular medicine, innovative medical technologies, ecosystem and information, communication technologies. Goal is: to reach global level in biotechnology, bio pharmacy and IT sectors. It is planed to create 1200 new work places. 5 times growth in biotechnology and bio pharmacy generated GDP (approx. up to 0,5% of GDP per year). 2

3 Santara Valley Development

4 The facilities: Santara Valley Hospital and laboratories of 5 research institutes 2 GMP-compliant pharmaceuticals plants 4 high-tech R&D facilities The business: Biotechpharma R&D and Production plant, TEVA biotech plant, MOOG Medical Devices plant, Valentis Pharma plant, Baltic Solar Energy plant Public sector: Institute of Innovative Medicine, Institute of Biochemistry, Institute of Mathematics and Informatics, Environmental research center, Institute of Oncology - Healthcare / Hospital - Public research institutions - Private R&D and manufacturing centers - Business incubators / STP 4

5 Valleys monitoring group is composed from Lithuanian and foreign experts. 100 mln. EUR were invested in Santara valley Several R&D sectors are going to be developed: biotechnology, bio pharmacy, innovative medicine technologies, molecular medicine, Santara Valley solar batteries and IT technologies 5

6 Biotechnologies Sicor Biotech and Biotechpharma both biopharmaceuticals developers and producers are members of Santara Valley New biopharmaceutical for hepatitis C is being developed and produced in Biotechpharma Monoclonal antibodies used for different purposes are in stage of development Bio similars are developed and produced. Sicor biotech has developed and is producing GCSF, which has passed EMA and FDA audits 6

7 Innovative Medicine center New research and development center for innovative medicine and biopharmasy is being built in Santara Valley sq. m. for different purposes laboratories and Open laboratories. Laboratories for research: immunotechnology, biopharmaceutical processes, biomedical information and visualization algorithms, innovative medical technologies, bio models, stem cells. 7

8 Medicine Vilnius University hospital Santariškių Klinikos is a hospital constantly investing in innovative medicine technologies Development of : Medical imaging Health system online E-HEALTH Molecular diagnostics Personalised medicine Minimal invasion technologies Clinical research infrastructure 8

9 Medical devices MOOG Medical Devices a member of Santara valley Development of medical technologies Research for new technologies Producing innovative injection medical devices 9

10 Results Santara valley is developing according to the program: there are well established scientific centers, established new biotechnology company Biotechpharma, MOOG medical devices invested in their research and development center, Vilniaus Universiteto Sanatarškių klinikos are establishing new centers and providing new innovative medicine services. 10

11 Results Innovative product development and scientific research is being promoted by combining private and public entities. In ,3% of GDP was generated by biotech and bio pharmacy companies 3 times increase since Global investors identify Santara Valley as a Innovation Hub of Northern Europe. Global companies are investing in infrastructure or outsourcing their R&D and other biotech services. 11

12 Thank you 12